Cannabis abuse as a risk factor for depressive symptoms.
paper
Cited
Public
Unavailable
- Authors
- Bovasso, G B
- Year
- 2001
- Journal
- The American journal of psychiatry
- PMID
- 11729021
- DOI
- 10.1176/appi.ajp.158.12.2033
OBJECTIVE: This study sought to estimate the degree to which cannabis abuse is a risk factor for depressive symptoms rather than an effort to self-medicate depression. METHOD: Participants (N=1,920) in the 1980 Baltimore Epidemiologic Catchment Area (ECA) study who were reassessed between 1994 and 1996 as part of a follow-up study provided the data. The analysis focused on two cohorts: those who reported no depressive symptoms at baseline (N=849) and those with no diagnosis of cannabis abuse at baseline (N=1,837). Symptoms of depression, cannabis abuse, and other psychiatric disorders were assessed with the Diagnostic Interview Schedule. RESULTS: In participants with no baseline depressive symptoms, those with a diagnosis of cannabis abuse at baseline were four times more likely than those with no cannabis abuse diagnosis to have depressive symptoms at the follow-up assessment, after adjusting for age, gender, antisocial symptoms, and other baseline covariates. In particular, these participants were more likely to have experienced suicidal ideation and anhedonia during the follow-up period. Among the participants who had no diagnosis of cannabis abuse at baseline, depressive symptoms at baseline failed to significantly predict cannabis abuse at the follow-up assessment. CONCLUSIONS: Further research is needed to identify characteristics of individuals who abuse cannabis that account for their higher risk of depression to estimate the degree of impairment resulting from their depression.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks. | 2016 | 27028160 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Problematic cannabis use and attachment insecurities as Joint predictors of Depression: Cross-Sectional and longitudinal models. | Gliksberg O et al. | β | 2026 | β |
| Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential. | Botsford SL et al. | β | 2025 | β |
| Cannabis use and suicide: a case-control study based on integrative data analysis. | Shi Q et al. | β | 2025 | β |
| Characterizing proximal risk for depressive symptoms and suicidal ideation with acute cannabis use and withdrawal among adolescents using ecological momentary assessment: Study protocol. | Feibus I et al. | β | 2025 | β |
| Effects of Cannabis Exposure on Adolescent Health and Development: A Narrative Review. | Li R et al. | β | 2025 | β |
| The association between cannabis and depression: an updated Systematic Review and Meta-analysis. | Churchill V et al. | β | 2025 | β |
| The role of depression in the relationship between cannabis use and suicidal behaviours: A systematic review and meta-analysis. | Maffre Maviel G et al. | β | 2025 | β |
| Cannabis and anhedonia: A systematic review. | Poyatos-Pedrosa C et al. | β | 2024 | β |
| Cannabis use and mood disorders: a systematic review. | Sorkhou M et al. | β | 2024 | β |
| From mood to use: Using ecological momentary assessments to examine how anhedonia and depressed mood impact cannabis use in a depressed sample. | Collins AC et al. | β | 2024 | β |
| Inclusion of Individuals With Lived Experiences in the Development of a Digital Intervention for Co-Occurring Depression and Cannabis Use: Mixed Methods Investigation. | Collins AC et al. | β | 2024 | β |
| Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and Long COVID-19-A Scoping Review. | Scott C et al. | β | 2023 | β |
| Clinical Characteristics, Support System, and Personality Differences of Cannabis and Stimulant Users in South Korea. | Jang J et al. | β | 2023 | β |
| Altered large-scale brain network interactions associated with HIV infection and error processing. | Flannery JS et al. | β | 2022 | β |
| Association between cannabis use and suicidal behavior: A systematic review of cohort studies. | Carvalho JV et al. | β | 2022 | β |
| Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence. | Kuhns L et al. | β | 2022 | β |
| Associations Between Outcome Resilience and Sociodemographic Factors, Childhood Trauma, Personality Dimensions and Self-Rated Health in Middle-Aged Adults. | Linnemann P et al. | β | 2022 | β |
| Frequent Cannabis Use Moderates the Relationship Between Sexual Dysfunction and Depression Among Female German Adults. | Belau MH et al. | β | 2022 | β |
| Increased cannabis intake during the COVID-19 pandemic is associated with worsening of depression symptoms in people with PTSD. | Murkar A et al. | β | 2022 | β |
| Managing Pain and Discomfort in Children with Cancer. | Fuller C et al. | β | 2022 | β |
| Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence. | Bright U et al. | β | 2022 | β |
| Psychological distress in a sample of Moroccan prisoners with drug-dependence. | Sfendla A et al. | β | 2022 | β |
| Yet Again Conversations Matter: The Importance of Interpersonal Discussions, Educational Campaigns, and Advertising on Cannabis-Related Risk Perceptions, Attitudes, and Intentions in At-Risk Young Adults. | Tveleneva A et al. | β | 2022 | β |
| Assessing Changes in Symptoms of Depression and Anxiety During Four Weeks of Cannabis Abstinence Among Adolescents. | Cooke ME et al. | β | 2021 | β |
| Cannabis and Depression. | Feingold D et al. | β | 2021 | β |
| Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses. | Breijyeh Z et al. | β | 2021 | β |
| Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis. | Blum K et al. | β | 2021 | β |
| Comorbid Cannabis Use Disorder with Major Depression and Generalized Anxiety Disorder: A Systematic Review with Meta-analysis of Nationally Representative Epidemiological Surveys. | Onaemo VN et al. | β | 2021 | β |
| Endocannabinoid-serotonin systems interaction in health and disease. | Colangeli R et al. | β | 2021 | β |
| Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. | Tomko RL et al. | β | 2020 | β |
| Does substance use explain social differences in terms of depression? Findings from the Constances cohort. | Matta J et al. | β | 2020 | β |
| Longitudinal associations between negative urgency, symptoms of depression, cannabis and alcohol use in veterans. | Gunn RL et al. | β | 2020 | β |
| The relationship between psychological health and social support: Evidence from physicians in China. | Sun J et al. | β | 2020 | β |
| An Examination of Comorbid Psychiatric Disorders in Disordered Gamblers Versus Other Substance-Related Disorders. | Nicholson R et al. | β | 2019 | β |
| Insights into the role of cannabis in the management of inflammatory bowel disease. | Picardo S et al. | β | 2019 | β |
| The effects of acute stress on consummatory and motivational responses for sucrose in rats after long-term withdrawal from morphine. | Bai Y et al. | β | 2019 | β |
| Young Adult Mental Health: a Prospective Examination of Service Utilization, Perceived Unmet Service Needs, Attitudes, and Barriers to Service Use. | Cadigan JM et al. | β | 2019 | β |
| Association between School Membership and Substance Use among Adolescents. | Gaete J et al. | β | 2018 | β |
| Cannabis and Mood Disorders. | Lucatch AM et al. | β | 2018 | β |
| Cannabis Use Among Remote Indigenous Australians: Opportunities to Support Change Identified in Two Waves of Sampling. | Graham VE et al. | β | 2018 | β |
| Genetic and environmental influences on the codevelopment among borderline personality disorder traits, major depression symptoms, and substance use disorder symptoms from adolescence to young adulthood. | Bornovalova MA et al. | β | 2018 | β |
| Is Cannabis Use Treatment Also Indicated for Patients with Low to Moderate Polysubstance Use. | Neumann M et al. | β | 2018 | β |
| Marijuana Use and Depressive Symptoms; Gender Differences in African American Adolescents. | Assari S et al. | β | 2018 | β |
| Medical marijuana in pediatric oncology: A review of the evidence and implications for practice. | Ananth P et al. | β | 2018 | β |
| Mental Health-related Emergency Department Visits Associated With Cannabis in Colorado. | Hall KE et al. | β | 2018 | β |
| Mood Fluctuation and Psychobiological Instability: The Same Core Functions Are Disrupted by Novel Psychoactive Substances and Established Recreational Drugs. | Parrott AC | β | 2018 | β |
| Negative urgency partially accounts for the relationship between major depressive disorder and marijuana problems. | Gunn RL et al. | β | 2018 | β |
| Preliminary Outcomes of a Computerized CBT/MET Intervention for Depressed Cannabis Users in Psychiatry Care. | Glasner S et al. | β | 2018 | β |
| Risk and protective factors for drug dependence in two Moroccan high-risk male populations. | Sfendla A et al. | β | 2018 | β |
| Sex and age differences in risk factors of marijuana involvement during adolescence. | Chen LY et al. | β | 2018 | β |
| Triple trajectories of alcohol use, tobacco use, and depressive symptoms as predictors of cannabis use disorders among urban adults. | Lee JY et al. | β | 2018 | β |
| Acute stress worsens the deficits in appetitive behaviors for social and sexual stimuli displayed by rats after long-term withdrawal from morphine. | Bai Y et al. | β | 2017 | β |
| A Multigroup, Longitudinal Study of Truant Youths, Marijuana Use, Depression, and STD-Associated Sexual Risk Behavior. | Dembo R et al. | β | 2017 | β |
| Associations between anhedonia and marijuana use escalation across mid-adolescence. | Leventhal AM et al. | β | 2017 | β |
| Cannabis and Depression: A Twin Model Approach to Co-morbidity. | Smolkina M et al. | β | 2017 | β |
| Cannabis and development of dual diagnoses: A literature review. | Hanna RC et al. | β | 2017 | β |
| Cannabis exacerbates depressive symptoms in rat model induced by reserpine. | Khadrawy YA et al. | β | 2017 | β |
| Cannabis use and the course and outcome of major depressive disorder: A population based longitudinal study. | Feingold D et al. | β | 2017 | β |
| Cannabis use disorder and suicide attempts in Iraq/Afghanistan-era veterans. | Kimbrel NA et al. | β | 2017 | β |
| Epidemiology and evolution of the diagnostic classification of factitious disorders in <i>DSM-5</i>. | Caselli I et al. | β | 2017 | β |
| Evidence that anhedonia is a symptom of opioid dependence associated with recent use. | Garfield JBB et al. | β | 2017 | β |
| Medical cannabis and mental health: A guided systematic review. | Walsh Z et al. | β | 2017 | β |
| Neural Correlates of Social Influence Among Cannabis Users. | Gilman JM | β | 2017 | β |
| Recreational stimulants, herbal, and spice cannabis: The core psychobiological processes that underlie their damaging effects. | Parrott AC et al. | β | 2017 | β |
| Role of vasopressin V1a receptor in β<sup>9</sup>-tetrahydrocannabinol-induced cataleptic immobilization in mice. | Egashira N et al. | β | 2017 | β |
| The consequences of chronic cannabis smoking in vulnerable adolescents. | Iede MA et al. | β | 2017 | β |
| The genetic basis of the comorbidity between cannabis use and major depression. | Hodgson K et al. | β | 2017 | β |
| Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses. | Lawn W et al. | β | 2016 | β |
| A literature review and meta-analyses of cannabis use and suicidality. | Borges G et al. | β | 2016 | β |
| Altered Neural Processing to Social Exclusion in Young Adult Marijuana Users. | Gilman JM et al. | β | 2016 | β |
| Anxiety, depression and risk of cannabis use: Examining the internalising pathway to use among Chilean adolescents. | Stapinski LA et al. | β | 2016 | β |
| Bidirectional Associations Between Cannabis Use and Depressive Symptoms From Adolescence Through Early Adulthood Among At-Risk Young Men. | Womack SR et al. | β | 2016 | β |
| Ecological momentary assessment of affect and craving in patients in treatment for prescription opioid dependence. | Huhn AS et al. | β | 2016 | β |
| Evidence of anhedonia and differential reward processing in prefrontal cortex among post-withdrawal patients with prescription opiate dependence. | Huhn AS et al. | β | 2016 | β |
| Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks. | Sherva R et al. | β | 2016 | β |
| Investigation of a Suicide Ideation Risk Profile in People With Co-occurring Depression and Substance Use Disorder. | Handley TE et al. | β | 2016 | β |
| Multisubstance Use Among Treatment-Seeking Smokers: Synergistic Effects of Coping Motives for Cannabis and Alcohol Use and Social Anxiety/Depressive Symptoms. | Foster DW et al. | β | 2016 | β |
| REDUCTIONS IN CANNABIS USE ARE ASSOCIATED WITH MOOD IMPROVEMENT IN FEMALE EMERGING ADULTS. | Moitra E et al. | β | 2016 | β |
| Attention to pleasant stimuli in early adolescence predicts alcohol-related problems in mid-adolescence. | Garfield JB et al. | β | 2015 | β |
| Bidirectional Influence: A Longitudinal Analysis of Size of Drug Network and Depression Among Inner-City Residents in Baltimore, Maryland. | Yang J et al. | β | 2015 | β |
| Cannabis use and mental health-related quality of life among individuals with depressive disorders. | Aspis I et al. | β | 2015 | β |
| Chronic adolescent marijuana use as a risk factor for physical and mental health problems in young adult men. | Bechtold J et al. | β | 2015 | β |
| Depression in late adolescence: a cross-sectional study in senior high schools in Greece. | Magklara K et al. | β | 2015 | β |
| Evidence that the presence of psychosis in non-psychotic disorder is environment-dependent and mediated by severity of non-psychotic psychopathology. | Guloksuz S et al. | β | 2015 | β |
| Interpersonal guilt and substance use in college students. | Locke GW et al. | β | 2015 | β |
| Prevalence of medical marijuana use in California, 2012. | Ryan-Ibarra S et al. | β | 2015 | β |
| Replication of a whole school ethos-changing intervention: different context, similar effects, additional insights. | Hawe P et al. | β | 2015 | β |
| The association between cannabis use and mood disorders: A longitudinal study. | Feingold D et al. | β | 2015 | β |
| Variations in Cannabis Use Level and Correlates in Opiate-Users on Methadone Maintenance Treatment: A French Prospective Study. | Mayet A et al. | β | 2015 | β |
| A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior. | McLaughlin RJ et al. | β | 2014 | β |
| Anhedonia in substance use disorders: a systematic review of its nature, course and clinical correlates. | Garfield JB et al. | β | 2014 | β |
| A service-level action research intervention to improve identification and treatment of cannabis and related mental health issues in young Indigenous Australians: a study protocol. | Bohanna I et al. | β | 2014 | β |
| Atypical Epidemiologic Finding in Association between Depression and Alcohol Use or Smoking in Korean Male: Korean Longitudinal Study of Aging. | Noh JW et al. | β | 2014 | β |
| Cannabis use expectancies mediate the relation between depressive symptoms and cannabis use among cannabis-dependent veterans. | Farris SG et al. | β | 2014 | β |
| Cannabis use is a better indicator of poor mental health in women than in men: a cross-sectional study in young adults from the general population. | van Gastel WA et al. | β | 2014 | β |
| Comorbid psychiatric disorders and stages of change in cannabis-dependent, treatment-seeking patients. | Oliveira HP et al. | β | 2014 | β |
| Co-Occurring Depressive and Substance Use Disorders in Adolescents: An Examination of Reward Responsiveness During Treatment. | Boger KD et al. | β | 2014 | β |
| Do reward-processing deficits in schizophrenia-spectrum disorders promote cannabis use? An investigation of physiological response to natural rewards and drug cues. | Cassidy CM et al. | β | 2014 | β |
| Effect of alcohol use on the course of bipolar disorder: one-year follow-up study using the daily prospective Life Chart method. | van Zaane J et al. | β | 2014 | β |
| Endocannabinoid signaling in the etiology and treatment of major depressive illness. | Hillard CJ et al. | β | 2014 | β |
| Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort. | Roux P et al. | β | 2014 | β |
| Longitudinal associations between childhood and adulthood externalizing and internalizing psychopathology and adolescent substance use. | Miettunen J et al. | β | 2014 | β |
| Medical marijuana laws and suicides by gender and age. | Anderson DM et al. | β | 2014 | β |
| Patterns and correlates of cannabis use among individuals with HIV/AIDS in Maritime Canada. | Harris GE et al. | β | 2014 | β |
| Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology. | Yadav V et al. | β | 2014 | β |
| The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. | Lev-Ran S et al. | β | 2014 | β |
| Using cannabis to help you sleep: heightened frequency of medical cannabis use among those with PTSD. | Bonn-Miller MO et al. | β | 2014 | β |
| Depression in male patients on methadone maintenance therapy. | Baharudin A et al. | β | 2013 | β |
| Mental health differences between frequent cannabis users with and without dependence and the general population. | van der Pol P et al. | β | 2013 | β |
| Motivation for change and barriers to treatment among young cannabis users. | FernΓ‘ndez-Artamendi S et al. | β | 2013 | β |
| Posttraumatic stress disorder and cannabis use characteristics among military veterans with cannabis dependence. | Boden MT et al. | β | 2013 | β |
| Pregnancy, breast-feeding, and marijuana: a review article. | Hill M et al. | β | 2013 | β |
| Sleep quality moderates the relation between depression symptoms and problematic cannabis use among medical cannabis users. | Babson KA et al. | β | 2013 | β |
| The moderating effect of parental illicit substance use disorders on the relation between adolescent depression and subsequent illicit substance use disorders. | Gorka SM et al. | β | 2013 | β |
| Antidepressant-like effects of ΞβΉ-tetrahydrocannabinol and rimonabant in the olfactory bulbectomised rat model of depression. | Elbatsh MM et al. | β | 2012 | β |
| Assessing topographical orientation skills in cannabis users. | Palermo L et al. | β | 2012 | β |
| Cannabis and depression: an integrative data analysis of four Australasian cohorts. | Horwood LJ et al. | β | 2012 | β |
| Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. | Hillard CJ et al. | β | 2012 | β |
| Exploratory study of the psychopathological profiles of adolescent cannabis users. | Chabrol H et al. | β | 2012 | β |
| Long-term behavioral and biochemical effects of an ultra-low dose of Ξ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling. | Fishbein M et al. | β | 2012 | β |
| Mechanisms underlying the link between cannabis use and prospective memory. | Cuttler C et al. | β | 2012 | β |
| Parallel Development of Risk Behaviors in Adolescence: Potential Pathways to Co-occurrence. | Huang DY et al. | β | 2012 | β |
| Revisiting the concepts of risk and protective factors for understanding the etiology and development of substance use and substance use disorders: implications for prevention. | Sloboda Z et al. | β | 2012 | β |
| Sex differences in nicotine dependence among addictions clients accessing a smoking cessation programme in Vancouver, British Columbia, Canada. | Okoli CT et al. | β | 2012 | β |
| State of the art treatments for cannabis dependence. | Danovitch I et al. | β | 2012 | β |
| The impact of comorbid cannabis use disorders on the clinical presentation of social anxiety disorder. | Tepe E et al. | β | 2012 | β |
| Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects. | Martinotti G et al. | β | 2011 | β |
| A controlled trial of an internet-based intervention program for cannabis users. | Tossmann HP et al. | β | 2011 | β |
| Anhedonia and substance dependence: clinical correlates and treatment options. | Hatzigiakoumis DS et al. | β | 2011 | β |
| Anxiety sensitivity as a mediator of the relationship between moderate-intensity exercise and coping-oriented marijuana use motives. | Smits JA et al. | β | 2011 | β |
| Association between cannabis and psychiatric hospitalization. | Schubart CD et al. | β | 2011 | β |
| Depression and psychological distress in tobacco smokers and people with cannabis dependence in the National Survey of Mental Health and Wellbeing. | Mathews RR et al. | β | 2011 | β |
| Marijuana use among older adults in the U.S.A.: user characteristics, patterns of use, and implications for intervention. | Dinitto DM et al. | β | 2011 | β |
| Medical marijuana use and suicide attempt in a patient with major depressive disorder. | Nussbaum A et al. | β | 2011 | β |
| Patterns of alcohol and drug use among depressed older adults seeking outpatient psychiatric services. | Satre DD et al. | β | 2011 | β |
| Sex differences in smoking cessation outcomes of a tailored program for individuals with substance use disorders and mental illness. | Okoli CT et al. | β | 2011 | β |
| Substance use/abuse and suicidal behavior in young adult women: a population-based study. | Sundin M et al. | β | 2011 | β |
| The tobacco-dependence clinic: intensive tobacco-dependence treatment in an addiction services outpatient setting. | Khara M et al. | β | 2011 | β |
| Trajectories of marijuana use and psychological adjustment among urban African American and Puerto Rican women. | Pahl K et al. | β | 2011 | β |
| Abnormal cerebellar morphometry in abstinent adolescent marijuana users. | Medina KL et al. | β | 2010 | β |
| A comparison of psychosocial and cognitive functioning between depressed and non-depressed patients with cannabis dependence. | Secora AM et al. | β | 2010 | β |
| Alcohol and drug use in suicidal behaviour. | Borges G et al. | β | 2010 | β |
| Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. | El-Alfy AT et al. | β | 2010 | β |
| Anxiety and mood disorders and cannabis use. | Cheung JT et al. | β | 2010 | β |
| Cannabidiol induces intracellular calcium elevation and cytotoxicity in oligodendrocytes. | Mato S et al. | β | 2010 | β |
| [Cannabis and mood]. | Sanches RF et al. | β | 2010 | β |
| Chronic effects of cannabis use on the human reward system: an fMRI study. | van Hell HH et al. | β | 2010 | β |
| Early cannabis use and estimated risk of later onset of depression spells: Epidemiologic evidence from the population-based World Health Organization World Mental Health Survey Initiative. | de Graaf R et al. | β | 2010 | β |
| Exploring the mediational role of coping motives for marijuana use in terms of the relation between anxiety sensitivity and marijuana dependence. | Johnson K et al. | β | 2010 | β |
| Longitudinal associations between depression and substance dependence from adolescence through early adulthood. | Marmorstein NR et al. | β | 2010 | β |
| Self-control and its relation to joint developmental trajectories of cannabis use and depressive mood symptoms. | Otten R et al. | β | 2010 | β |
| Uni-morbid and co-occurring marijuana and tobacco use: examination of concurrent associations with negative mood states. | Bonn-Miller MO et al. | β | 2010 | β |
| Cannabis and breastfeeding. | Garry A et al. | β | 2009 | β |
| Chronic toxicology of cannabis. | Reece AS | β | 2009 | β |
| Delta(9)-tetrahydrocannabinol enhances an increase of plasma corticosterone levels induced by forced swim-stress. | Sano K et al. | β | 2009 | β |
| Influence of depression and early adverse experiences on illicit drug dependence: a case-control study. | Ferigolo M et al. | β | 2009 | β |
| Is it time to consider cannabis smoking a cardiovascular risk factor? | Cappelli F et al. | β | 2009 | β |
| Longitudinal associations between alcohol problems and depressive symptoms: early adolescence through early adulthood. | Marmorstein NR | β | 2009 | β |
| Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects. | Medina KL et al. | β | 2009 | β |
| Relations between anxiety sensitivity, distress tolerance, and fear reactivity to bodily sensations to coping and conformity marijuana use motives among young adult marijuana users. | Zvolensky MJ et al. | β | 2009 | β |
| Role of endocannabinoid signaling in anxiety and depression. | Patel S et al. | β | 2009 | β |
| Subjective effects of cannabis before the first psychotic episode. | Peters BD et al. | β | 2009 | β |
| The familial aggregation of cannabis use disorders. | Merikangas KR et al. | β | 2009 | β |
| Adolescent cannabis problems and young adult depression: male-female stratified propensity score analyses. | Harder VS et al. | β | 2008 | β |
| Alcohol protracted withdrawal syndrome: the role of anhedonia. | Martinotti G et al. | β | 2008 | β |
| Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder. | Leventhal AM et al. | β | 2008 | β |
| Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects. | Onaivi ES et al. | β | 2008 | β |
| Cannabis and psychiatric disorders: it is not only addiction. | Leweke FM et al. | β | 2008 | β |
| Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system. | Egashira N et al. | β | 2008 | β |
| Dimensions of adolescent alcohol involvement as predictors of young-adult major depression. | Mason WA et al. | β | 2008 | β |
| DSM-IV criteria-based clinical subtypes of cannabis use disorders: results from the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). | Blanco C et al. | β | 2008 | β |
| Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression. | Onaivi ES et al. | β | 2008 | β |
| [Induced psychiatric and somatic disorders to cannabis]. | Laqueille X et al. | β | 2008 | β |
| Major depression: the relative contribution of gender, MDMA, and cannabis use. | Durdle H et al. | β | 2008 | β |
| Marijuana coping motives interact with marijuana use frequency to predict anxious arousal, panic related catastrophic thinking, and worry among current marijuana users. | Bonn-Miller MO et al. | β | 2008 | β |
| Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. | Hill MN et al. | β | 2008 | β |
| Temperament and character inventory dimensions and anhedonia in detoxified substance-dependent subjects. | Martinotti G et al. | β | 2008 | β |
| The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables. | Pozzi G et al. | β | 2008 | β |
| The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. | Bambico FR et al. | β | 2008 | β |
| The relationship between depressive symptom levels and subsequent increases in substance use among youth with severe emotional disturbance. | Wu P et al. | β | 2008 | β |
| A stepped care approach for reducing cannabis use in opioid-dependent outpatients. | Kidorf M et al. | β | 2007 | β |
| Cannabis and anxiety and depression in young adults: a large prospective study. | Hayatbakhsh MR et al. | β | 2007 | β |
| Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. | Moore TH et al. | β | 2007 | β |
| Characteristics of cocaine- and marijuana-dependent subjects presenting for medication treatment trials. | McRae AL et al. | β | 2007 | β |
| Depressive symptoms in adolescents: associations with white matter volume and marijuana use. | Medina KL et al. | β | 2007 | β |
| Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population? | van Laar M et al. | β | 2007 | β |
| Life-time cannabis use and late onset mood and anxiety disorders. | Lynskey MT | β | 2007 | β |
| Medical marijuana and the developing role of the pharmacist. | Seamon MJ et al. | β | 2007 | β |
| Motives for cannabis use as a moderator variable of distress among young adults. | Brodbeck J et al. | β | 2007 | β |
| Negative consequences associated with dependence in daily cannabis users. | Looby A et al. | β | 2007 | β |
| Psychiatric predictors of adolescent and young adult drug use and abuse: what have we learned? | Costello EJ | β | 2007 | β |
| [Substance use and psychiatric symptoms in subjects referred to the drug addiction services by the prefecture]. | Bizzarri JV et al. | β | 2007 | β |
| Anxiety sensitivity interacts with marijuana use in the prediction of anxiety symptoms and panic-related catastrophic thinking among daily tobacco users. | Zvolensky MJ et al. | β | 2006 | β |
| Cannabis use and mood disorders: patterns of clinical presentations among adolescents in a developing country. | Konings M et al. | β | 2006 | β |
| Co-morbidity of select anxiety, affective, and psychotic disorders with cannabis dependence in Southwest California Indians. | Gilder DA et al. | β | 2006 | β |
| Marijuana use and depression among adults: Testing for causal associations. | Harder VS et al. | β | 2006 | β |
| Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application. | Millan MJ | β | 2006 | β |
| Nicotine dependence, use of illegal drugs and psychiatric morbidity. | MartΓnez-Ortega JM et al. | β | 2006 | β |
| Severity of dependence and motivation for treatment: comparison of marijuana- and cocaine-dependent treatment seekers. | Levin FR et al. | β | 2006 | β |
| Smoking cessation and depression: current knowledge and future directions. | Wilhelm K et al. | β | 2006 | β |
| Temporal trends in rates of dual diagnoses at a Canadian addictions hospital over a five-year period. | Kolla NJ et al. | β | 2006 | β |
| Adverse mental health effects of cannabis use in two indigenous communities in Arnhem Land, Northern Territory, Australia: exploratory study. | Clough AR et al. | β | 2005 | β |
| Anhedonia and substance-related symptoms in detoxified substance-dependent subjects: a correlation study. | Janiri L et al. | β | 2005 | β |
| Comorbidity: cannabis and complexity. | Raphael B et al. | β | 2005 | β |
| Individual, family, school, and community risk and protective factors for depressive symptoms in adolescents: a comparison of risk profiles for substance use and depressive symptoms. | Bond L et al. | β | 2005 | β |
| The safety of cannabinoids for the treatment of multiple sclerosis. | Smith PF | β | 2005 | β |
| Cannabis and psychopathology : update 2004. | Grover S et al. | β | 2004 | β |
| Cannabis-associated psychosis: current status of research. | Leweke FM et al. | β | 2004 | β |
| Cannabis use and risk of psychosis: an etiological link? | Verdoux H et al. | β | 2004 | β |
| Gene-environment interplay in affect and dementia: emotional modulation of cognitive expression in personal outcomes. | Palomo T et al. | β | 2004 | β |
| Grey lungs and blue moods: smoking cessation in the context of lifetime depression history. | Wilhelm K et al. | β | 2004 | β |
| Is the party over? Cannabis and juvenile psychiatric disorder: the past 10 years. | Rey JM et al. | β | 2004 | β |
| [News about therapeutic use of Cannabis and endocannabinoid system]. | Duran M et al. | β | 2004 | β |
| [Relations between anxious, depressive and borderline symptomatology and frequency of cannabis use and dependence]. | Chabrol H et al. | β | 2004 | β |
| Role of endocannabinoid system in mental diseases. | Manzanares J et al. | β | 2004 | β |
| The Marijuana Screening Inventory (MSI-X): reliability, factor structure, and scoring criteria with a clinical sample. | Alexander DE et al. | β | 2004 | β |
| The obstetrician and depression during pregnancy. | Campagne DM | β | 2004 | β |
| The reality of comorbidity: depression and drug abuse. | Volkow ND | β | 2004 | β |
| Behavioural and gene transcription alterations induced by spontaneous cannabinoid withdrawal in mice. | Oliva JM et al. | β | 2003 | β |
| Depression in people living with HIV/AIDS attending primary care and outpatient clinics. | Komiti A et al. | β | 2003 | β |
| Exploring the association between cannabis use and depression. | Degenhardt L et al. | β | 2003 | β |
| Problems with odds ratios. | Epstein DH | β | 2003 | β |
| Substance use disorder comorbidity among inpatient youths with psychiatric disorder. | Swadi H et al. | β | 2003 | β |
| Cannabis and mental health. | Rey JM et al. | β | 2002 | β |
| Cannabis use and mental health in young people: cohort study. | Patton GC et al. | β | 2002 | β |
| Differential diagnosis of depressed mood in patients with schizophrenia: a diagnostic algorithm based on a review. | Hausmann A et al. | β | 2002 | β |